{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:02:45Z","timestamp":1789426965665,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,14]]},"DOI":"10.7759\/cureus.116240","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:10:26Z","timestamp":1789423826000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Significance of the Identification of an Anti-M (IgG) Alloantibody in Pregnancy"],"prefix":"10.7759","author":[{"given":"Alla","family":"Iashchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Sardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/tme.13098","article-title":"Guideline for the investigation and management of red cell antibodies in pregnancy: a British Society for Haematology guideline","volume":"35","author":"Regan F","year":"2025","unstructured":"Regan F, Veale K, Robinson F, et al.. Guideline for the investigation and management of red cell antibodies in pregnancy: a British Society for Haematology guideline. Transfus Med. 2025, 35:3-23. 10.1111\/tme.13098","journal-title":"Transfus Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2024.04.122","article-title":"Hemolytic disease of the fetus and newborn-a perspective of immunohematology","volume":"46","author":"Rodrigues MM","year":"2024","unstructured":"Rodrigues MM, Mattos D, Almeida S, Fiegenbaum M. Hemolytic disease of the fetus and newborn-a perspective of immunohematology. Hematol Transfus Cell Ther. 2024, 46:S246-57. 10.1016\/j.htct.2024.04.122","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14262","article-title":"Red blood cell alloimmunization in pregnancy during the years 1996-2015 in Iceland: a nation-wide population study","volume":"57","author":"Bollason G","year":"2017","unstructured":"Bollason G, Hjartardottir H, Jonsson T, Gudmundsson S, Kjartansson S, Halldorsdottir AM. Red blood cell alloimmunization in pregnancy during the years 1996-2015 in Iceland: a nation-wide population study. Transfusion. 2017, 57:2578-85. 10.1111\/trf.14262","journal-title":"Transfusion"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1607028","article-title":"Anti-M alloimmunization: management and outcome at a single institution","volume":"7","author":"Stetson B","year":"2017","unstructured":"Stetson B, Scrape S, Markham KB. Anti-M alloimmunization: management and outcome at a single institution. AJP Rep. 2017, 7:e205-10. 10.1055\/s-0037-1607028","journal-title":"AJP Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.150968","article-title":"Maternal anti-M induced hemolytic disease of newborn followed by prolonged anemia in newborn twins","volume":"9","author":"Arora S","year":"2015","unstructured":"Arora S, Doda V, Maria A, Kotwal U, Goyal S. Maternal anti-M induced hemolytic disease of newborn followed by prolonged anemia in newborn twins. Asian J Transfus Sci. 2015, 9:98-101. 10.4103\/0973-6247.150968","journal-title":"Asian J Transfus Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/vox.70316","article-title":"Haemolytic disease of the foetus and newborn due to anti-M: a systematic review","volume":"121","author":"Wang L","year":"2026","unstructured":"Wang L, Wang L, Huang Y, Cheng F, Tan B. Haemolytic disease of the foetus and newborn due to anti-M: a systematic review. Vox Sang. 2026, 121:1129-37. 10.1111\/vox.70316","journal-title":"Vox Sang"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/ajts.ajts_109_21","article-title":"Maternal allo anti-M antibody-induced hemolytic disease of newborn","volume":"16","author":"Mathew AM","year":"2022","unstructured":"Mathew AM, Shah S, Bhatnagar N, Shah M, Patel T, Thakkar T. Maternal allo anti-M antibody-induced hemolytic disease of newborn. Asian J Transfus Sci. 2022, 16:144-7. 10.4103\/ajts.ajts_109_21","journal-title":"Asian J Transfus Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7705\/biomedica.5930","article-title":"Hemolytic disease in fetuses and newborns due to antibodies against the M-antigen","volume":"41","author":"P\u00e1ez M","year":"2021","unstructured":"P\u00e1ez M, Jim\u00e9nez M, Corredor A. Hemolytic disease in fetuses and newborns due to antibodies against the M-antigen. Biomedica. 2021, 41:643-50. 10.7705\/biomedica.5930","journal-title":"Biomedica"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.22034\/iji.2023.93993.2273","article-title":"Maternal cold-reacting immunoglobulin G anti-M of MNS blood group system causing hemolytic disease of the fetus","volume":"20","author":"Liang YL","year":"2023","unstructured":"Liang YL, Shi Y, Su YQ, et al.. Maternal cold-reacting immunoglobulin G anti-M of MNS blood group system causing hemolytic disease of the fetus. Iran J Immunol. 2023, 20:129-34. 10.22034\/iji.2023.93993.2273","journal-title":"Iran J Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.crwh.2024.e00620","article-title":"Severe fetal hemolytic disease due to anti-M alloimmunization: a case report and literature review","volume":"42","author":"Golshahi F","year":"2024","unstructured":"Golshahi F, Sharbaf FR, Shirazi M, et al.. Severe fetal hemolytic disease due to anti-M alloimmunization: a case report and literature review. Case Rep Womens Health. 2024, 42:e00620. 10.1016\/j.crwh.2024.e00620","journal-title":"Case Rep Womens Health"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2017.04.022","article-title":"Prenatal treatment of severe fetal hemolytic disease due to anti-M alloimmunization by serial intrauterine transfusions","volume":"56","author":"Li L","year":"2017","unstructured":"Li L, Huang L, Luo G, Luo Y, Fang Q. Prenatal treatment of severe fetal hemolytic disease due to anti-M alloimmunization by serial intrauterine transfusions. Taiwan J Obstet Gynecol. 2017, 56:379-81. 10.1016\/j.tjog.2017.04.022","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1777995","article-title":"Double-filtration plasmapheresis and high-dose intravenous immunoglobulin therapy in a case of anti-M alloimmunization","volume":"14","author":"Yasuda S","year":"2024","unstructured":"Yasuda S, Ono-Okutsu M, Fukuda T, Kyozuka H, Fujimori K. Double-filtration plasmapheresis and high-dose intravenous immunoglobulin therapy in a case of anti-M alloimmunization. AJP Rep. 2024, 14:e101-5. 10.1055\/s-0043-1777995","journal-title":"AJP Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmad067","article-title":"Management of anti-M antibody during pregnancy: a case report","volume":"42","author":"Leibovitch ER","year":"2025","unstructured":"Leibovitch ER, Carlisle RT. Management of anti-M antibody during pregnancy: a case report. Fam Pract. 2025, 42:10.1093\/fampra\/cmad067","journal-title":"Fam Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1055\/a-2622-2841","article-title":"Confusing blood group antibodies in obstetrics: focus on the risk of hemolytic disease of the fetus and newborn","volume":"43","author":"Blackall DP","year":"2026","unstructured":"Blackall DP, Tomlinson MW. Confusing blood group antibodies in obstetrics: focus on the risk of hemolytic disease of the fetus and newborn. Am J Perinatol. 2026, 43:266-71. 10.1055\/a-2622-2841","journal-title":"Am J Perinatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.01.059","article-title":"Society for Maternal-Fetal Medicine (SMFM) clinical guideline #8: the fetus at risk for anemia-diagnosis and management","volume":"212","author":"Mari G","year":"2015","unstructured":"Mari G, Norton ME, Stone J, Berghella V, Sciscione AC, Tate D, Schenone MH. Society for Maternal-Fetal Medicine (SMFM) clinical guideline #8: the fetus at risk for anemia-diagnosis and management. Am J Obstet Gynecol. 2015, 212:697-710. 10.1016\/j.ajog.2015.01.059","journal-title":"Am J Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/528992-clinical-significance-of-the-identification-of-an-anti-m-igg-alloantibody-in-pregnancy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:10:27Z","timestamp":1789423827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/528992-clinical-significance-of-the-identification-of-an-anti-m-igg-alloantibody-in-pregnancy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.116240","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,14]]}}}